Q2 2023 · 13F-HR
BROADWOOD CAPITAL INCholdings as filed
Filed 2023-08-14 · accession 0000919574-23-004614
$1.34B
Reported value
7
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 61174X109 | MNST | MONSTER BEVERAGE CORP NEW | $534.9M | 40.0% | 9,312,976 | Common | SOLE |
| 852312305 | STAA | STAAR SURGICAL CO | $461.7M | 34.5% | 8,783,082 | Common | SOLE |
| 05464C101 | AXON | AXON ENTERPRISE INC | $148.3M | 11.1% | 760,062 | Common | SOLE |
| 464287655 | IWM | ISHARES TR | $129.2M | 9.66% | 690,000 | Common | SOLE |
| 53566P109 | LCTX | LINEAGE CELL THERAPEUTICS IN | $49.3M | 3.68% | 34,935,485 | Common | SOLE |
| 68235C107 | — | ONCOCYTE CORP | $11.5M | 0.86% | 50,181,335 | Common | SOLE |
| 00848H108 | AGEGBP | AGEX THERAPEUTICS INC | $2.7M | 0.20% | 2,997,156 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.